Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Seiedeh Bentolhoda Mousavi"'
Autor:
Ronak Mihan, Seiedeh Bentolhoda Mousavi, Mohammad Reza Khodaie Ardakani, Hamed Rezaei, Samaneh Hosseinzadeh, Rosa Alikhani
Publikováno v:
Iranian Journal of Psychiatry, Vol 18, Iss 2 (2023)
Objective: The burden on caregivers of patients with severe mental disorders is significantly higher than the care burden of patients with other medical conditions. Substance use disorder is also one of the most common psychiatric disorders that has
Externí odkaz:
https://doaj.org/article/347e0477ecb249d29f895982e476a962
Autor:
Mahjoube Goldani Moghadam, Sadegh Hosseini Sede, Seiedeh Bentolhoda Mousavi, Saeid Mohtasham, Alireza Ehteshampour, Rosa Alikhani, Hamed Aramjoo, Majid Zare_Bidaki
Publikováno v:
Interdisciplinary Journal of Virtual Learning in Medical Sciences, Vol 12, Iss 1, Pp 29-37 (2021)
Background: Fear of dental procedures is one of the main reasons why patients tend to avoid dental clinics. The present study aimed to investigate the effect of using Virtual Reality (VR) videos during dental treatments on anxiety levels of the adole
Externí odkaz:
https://doaj.org/article/3038ab57abc848d693c366f5ab52e8a6
Autor:
Areoo Samaei, Amir Ashraf-Ganjouei, Farzin Rezaei, Sayna Bagheri, Rosa Alikhani, Seiedeh Bentolhoda Mousavi, Kamyar Moradi, Shahin Akhondzadeh
Publikováno v:
International Journal of Neuropsychopharmacology
Background Patients with schizophrenia can generally manifest a broad variety of primary negative symptoms. The current study aimed to assess the efficacy and tolerability of resveratrol add-on therapy in the treatment of negative symptoms in patient
Autor:
Salomeh Ghaffari, Ali Aqamolaei, Ahmad Shamabadi, Mohammd Reza Shalbafan, Sina Naderi, Shahin Akhondzadeh, Rosa Alikhani, Seyyed Hosein Mortazavi, Erfan Sahebolzamani, Seiedeh Bentolhoda Mousavi, Shakiba Jalilevand, Arash Sadri, Amirhosein Mortezaei, Farzaneh Yousefzadeh
Publikováno v:
International Clinical Psychopharmacology. 35:254-262
On the basis of numerous previous studies, the serotonergic system plays a role in the pathogenesis of obsessive-compulsive disorder (OCD) and effective agents in this pathway, such as 5-hydroxytryptophan, can potentially contribute to treatment of p